Rare Care Podcast

101: An Interview With Rob Haselberg, an Huntington Patient Advocate Who Has Tested Positive for the Disease

100: An Interview With Herwig Lange, MD, President of the German Huntington Association

99: An Interview With Cathleen Lutz, PhD, Vice President of the Jackson Laboratory's Rare Disease Transactional Center

98: An Interview With Heather Stefanski, MD, PhD, Vice President of Medical Services at the National Marrow Donor Program's Be The Match

97: An Interview With Astri Arnesen, President and CEO of the European Huntington Association

96: An Interview With Derek de Winter, MD, Coordinating Investigator of the DIONYSUS Study

95: An Interview With Juan Valle, MB ChB, Chief Medical Officer of the Cholangiocarcinoma Foundation

94: An Interview With Prader-Willi Syndrome Patient Advocate Paige Rivard

93: An Interview With Italian Cholangiocarcinoma Expert Lorenza Rimassa, MD

92: An Interview With Jennifer Miller, MD, A Leading Researcher in Prader-Willi Syndrome

91: An Interview With Jennifer Knox, MD, Canada's Leading Expert in Cholangiocarcinoma

90: An Interview With Daniel Fischer, President and CEO of Tevard Biosciences

89: An interview with Damon Race, CEO of GeneVentive Therapeutics

88: An Interview With Pediatrician and Medical Cannabis Specialist Bonni Goldstein, MD

87: An Interview With Jason Sicklick, MD, FACS, an Expert on Gastrointestinal Stromal Tumor

86: An Interview With Kattayoun Kordy, MD, Senior Director of Rare Disease Clinical Development/Immunology at Janssen

85: An Interview with Denise Scots-Knight, PhD, CEO of Mereo BioPharma

84: Rare Disease Advisor

83: An Interview with Kim Smith-Whitley, MD

82: An Interview with Jason Tardio, Chief Operating Officer of Ovid Therapeutics